Your financials show the past. Your dashboards show the present. Neither one diagnoses either — not the break that’s already open and quietly costing you money today, and not the fracture forming twelve to twenty-four months out: the contract that reprices, the account that concentrates, the leader who’s compensating, the successor who isn’t there. Both are measurable now, from your own data. That is what we do.
Every company that breaks was measurable before it broke. The customer concentration was in the revenue ledger. The founder dependency was in the calendar. The margin leak was in the pricing file. The succession gap was in the org chart. The data was there — sitting in systems that record but never diagnose.
Fulcrum reads across those systems the way an MRI reads a body: not the X-ray that shows the break after it happens, but the scan that finds the fracture already there and the one forming beneath the surface. Every finding is computed from your own data and cited to the line it was read from. Nothing asserted. Nothing borrowed from a benchmark of companies that aren’t yours.
A SaaS company. Profitable, well-liked product, hard-working team — and stuck at $50 million for three straight years. The dashboard said fine. The CEO could feel that fine wasn’t the whole truth, and he couldn’t prove it.
Here’s what the dashboard couldn’t say: the company was losing 22.5 percent of its customers a month — and signing almost exactly that many new ones. Not a plateau. A treadmill. They knew about the churn, and they were spending millions a year trying to outspend it — plugging the hole without ever fixing the leak, because from every single seat the problem looked like someone else’s.
Then every department saw the whole play at once. Churn went from 22.5 percent to under 2 percent — one month after the diagnostic. Not one of the fixes was expensive, and not one of them was hard. The right small move in the right place moves something far bigger than itself. That’s a fulcrum.
Underneath every Fulcrum engagement sit eight instruments no competing diagnostic runs — each anchored in named, published research, each producing a score with a stated methodology behind it.
The composite read of the leadership system across four pillars: Business Mastery, Personal Evolution, Physical Vitality, Purpose & Legacy.
Not how healthy each leader is — how far apart they are. The variance between what the CEO believes and what the team experiences.
How much of the company routes through one person — decisions, relationships, knowledge — and what it costs to transfer.
Depletion signals that predict performance degradation before it surfaces as a missed quarter or a resignation.
Concentration, durability, and the Treadmill Ratio — how much new revenue you must win each quarter just to stand still.
The gap between the culture the leader describes and the culture the team lives in.
Which role, capability, or bench gap becomes the binding constraint on the next stage of growth.
Per-role continuity exposure: who holds what, who could hold it tomorrow, and where the answer is nobody.
Eight tiers, pre-revenue to $500M+. The full instrument suite run against your company, your team, and you — with a quantified risk model and a transformation blueprint, not a survey summary.
EXPLORE THE DIAGNOSTICS →Reads your financial and operational data and returns the exposures your dashboards can’t surface: the concentration cliff, the margin leak, the cash squeeze forming while the P&L still looks fine. Every finding computed, sourced, and priced in dollars.
SEE WHAT IT FINDS →Fourteen capital paths scored against five readiness dimensions. Fee-transparent: no placement compensation, no marketplace, no take-rate — the recommendation runs wherever the evidence points.
MAP YOUR CAPITAL →Pre-runs the buyer’s lens 18–24 months early: the sell-side earnings workup, the repricing risks, the value gap, and the plan that closes it. Diagnostic and preparation — never brokerage.
READ THE EXIT PICTURE →Not adoption theater. A scored read of AI’s real effect across seven operating domains, with a continue / restructure / sunset / expand call on every deployment — each net of the supervision, integration, and rework cost nobody loads against it.
AUDIT YOUR AI →Because it is one — until the system exists. We install the machine: readiness gate, scorecards, sourcing map, structured interview and work-sample, 30/60/90 onboarding, founder transfer plan.
BUILD THE MACHINE →Three free instruments, each returning a real, specific signal in minutes — a live demonstration of what the full engagements do, self-administered.
Your leadership system scored across all four pillars, calibrated to your revenue stage.
RUN IT →Twelve questions; a two-page report written to your answers, not a template.
SCAN IT →Where you stand across the dimensions a buyer prices — free, or $2,500 for the deeper read, credited in full toward any Exit engagement.
CHECK IT →
You’ve got advisors for the company. Who do you have for you? A standing 1:1 cadence with Ryan Erickson across the business, the money, the personal, and the part underneath all of it — the same four pillars the diagnostics measure. Most leaders have a dozen people who want something from them and nobody who tells them the truth. No diagnostic required. Capacity deliberately limited.
Thirty minutes. Your stage, your pressure points, and whether the engagement fits. No pitch.
Structured measurement across the instruments your tier calls for. Every number derived from your data — no borrowed benchmarks.
A quantified risk model, a dollar figure on each exposure, and a sequenced blueprint. You’ll learn things about your company you had no idea were happening.
Remediation with accountability architecture — through mentoring, the Mirror, or your own team with the Findings Tracker keeping score.
Fulcrum & Co. is the diagnostic practice of Ryan Erickson — two companies built from zero and exited, both successful; COO of a 275-person organization whose revenue doubled in three years; 25+ years operating; 20+ CEOs mentored. The companies he mentors and diagnoses run from pre-revenue founders to a client clearing $2 billion this year — including the company in the story, taken on at $50 million flat and tracking to $1.7 billion in year four. Every engagement routes through him. Every finding is reviewed before it reaches you. The firm is deliberately small, deliberately senior, and deliberately independent: no placement fees, no transaction compensation, no incentive to tell you anything but what your data says.